ReShape Lifesciences Inc. (RSLS) DCF Valuation

ReShape Lifesciences Inc. (RSLS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

ReShape Lifesciences Inc. (RSLS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate the financial outlook of ReShape Lifesciences Inc. (RSLS) like an expert! This (RSLS) DCF Calculator comes with pre-filled financials and offers you the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to match your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 15.1 11.3 13.6 11.2 8.7 7.7 6.8 6.1 5.4 4.8
Revenue Growth, % 0 -25.12 20.36 -17.35 -22.79 -11.22 -11.22 -11.22 -11.22 -11.22
EBITDA -17.2 -18.1 -60.6 -24.9 -14.5 -7.7 -6.8 -6.1 -5.4 -4.8
EBITDA, % -114.15 -160.15 -445.71 -221.75 -166.92 -100 -100 -100 -100 -100
Depreciation .9 1.7 2.0 2.2 .2 .9 .8 .7 .6 .5
Depreciation, % 5.92 14.75 14.49 19.15 1.77 11.22 11.22 11.22 11.22 11.22
EBIT -18.1 -19.8 -62.6 -27.1 -14.6 -7.7 -6.8 -6.1 -5.4 -4.8
EBIT, % -120.07 -174.9 -460.21 -240.91 -168.69 -100 -100 -100 -100 -100
Total Cash 2.9 3.0 22.8 3.9 4.5 3.6 3.2 2.8 2.5 2.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.1 2.6 2.8 2.2 1.7
Account Receivables, % 27.15 23.19 20.7 19.4 19.12
Inventories 1.3 2.2 3.0 3.6 3.7 1.9 1.7 1.5 1.4 1.2
Inventories, % 8.73 19.86 22.08 32.13 43.11 25.18 25.18 25.18 25.18 25.18
Accounts Payable 4.3 3.7 3.5 1.9 1.7 1.9 1.7 1.5 1.3 1.2
Accounts Payable, % 28.25 32.35 25.5 17.14 19.46 24.54 24.54 24.54 24.54 24.54
Capital Expenditure .0 -.4 -.4 -.1 .0 -.1 -.1 -.1 -.1 -.1
Capital Expenditure, % -0.09278282 -3.45 -2.59 -1.17 -0.49551 -1.56 -1.56 -1.56 -1.56 -1.56
Tax Rate, % -0.45876 -0.45876 -0.45876 -0.45876 -0.45876 -0.45876 -0.45876 -0.45876 -0.45876 -0.45876
EBITAT -17.9 -19.6 -62.5 -26.9 -14.7 -7.7 -6.8 -6.0 -5.4 -4.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -18.2 -18.4 -62.0 -26.4 -14.4 -4.9 -5.9 -5.3 -4.7 -4.2
WACC, % 8.5 8.51 8.52 8.51 8.52 8.51 8.51 8.51 8.51 8.51
PV UFCF
SUM PV UFCF -19.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -4
Terminal Value -65
Present Terminal Value -43
Enterprise Value -63
Net Debt -4
Equity Value -59
Diluted Shares Outstanding, MM 0
Equity Value Per Share -574.14

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: ReShape Lifesciences Inc.'s (RSLS) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that tailors to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life RSLS Financials: Pre-filled historical and projected data for ReShape Lifesciences Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate ReShape’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize ReShape’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file containing ReShape Lifesciences Inc. (RSLS) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
  • 5. Present with Assurance: Deliver professional valuation insights to back your decisions.

Why Choose ReShape Lifesciences Inc. (RSLS) Calculator?

  • Comprehensive Tool: Offers robust analyses including market potential, cost-effectiveness, and patient outcomes.
  • Customizable Inputs: Modify highlighted fields to explore different healthcare scenarios.
  • Detailed Insights: Automatically computes the intrinsic value and projected growth of ReShape Lifesciences Inc. (RSLS).
  • Preloaded Data: Access to historical performance and future projections for informed decision-making.
  • Professional Quality: Perfect for healthcare analysts, investors, and medical consultants.

Who Should Use ReShape Lifesciences Inc. (RSLS)?

  • Healthcare Investors: Make informed investment choices with cutting-edge insights into the medical device sector.
  • Market Analysts: Streamline your research with comprehensive data on ReShape Lifesciences' product offerings.
  • Consultants: Easily tailor presentations or reports focused on innovative weight loss solutions.
  • Health Enthusiasts: Enhance your knowledge of bariatric products and their impact on patient care.
  • Academics and Students: Utilize it as a valuable resource for studies in healthcare and medical technology.

What the Template Contains

  • Historical Data: Includes ReShape Lifesciences Inc.'s (RSLS) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate ReShape Lifesciences Inc.'s (RSLS) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of ReShape Lifesciences Inc.'s (RSLS) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.